Nature’s most potent antioxidants - research-validated - defend your brain, heart & metabolic health
Invasive Lobular Carcinoma - Understanding and Treatment
Invasive lobular carcinoma (ILC) is a unique and often overlooked type of breast cancer. Discover its distinct spread, complications like lymphedema, and actionable advice to empower your healing journey. Learn how to navigate breast cancer treatment effectively.
CANCERBONE HEALTH
AlexanderJ
8/26/20255 min read


Understanding Invasive Lobular Carcinoma (ILC)
ILC accounts for 10–15% of breast cancers, tending to progress more slowly and often staying hormone receptor–positive. Compared to other types, outcomes for metastatic ILC can be surprisingly favorable, especially with early detection and targeted treatment. ILC commonly spreads to bones rather than organs like the liver or lungs, meaning certain supportive therapies have a unique impact on quality and longevity of life.
Tocotrienols (T3) - Potent Anti-Cancer and Bone-Supportive Effects
Annatto-derived tocotrienols are a type of vitamin E showing profound anti-cancer activity in laboratory and mouse studies. Research demonstrates T3 can:
Induce apoptosis (cell death) in breast cancer cells
Sensitise tumour cells to conventional therapies, and target estrogen receptor pathways
Promote bone mineralisation and formation, making it useful for those with bone metastases and osteoporosis concerns.
Even more, animal models suggest T3 supplements can reduce tumour size, number, and delay metastases development.
Geranylgeraniol (GG) - Cellular Support in Your Cancer Protocol
The isoprenoid GG, while not yet widely studied directly for breast cancer, belongs to a family of compounds (including geraniol) shown to:
Inhibit cancer cell growth and induce apoptosis
Help maintain cell membrane integrity and support critical gene expression needed to fight cancer
Mitigate side effects of statin therapies, which are sometimes used in cancer protocols.
GG’s specific cellular signalling role may help reduce tumour spread and support therapy resilience.
The D3–K2–Magnesium Trio - A Foundation for Bone and Heart Health
Many people with breast cancer and bone metastases are keen to support their bones with calcium and vitamin D, but recent evidence highlights the danger of taking calcium with D3 without also supplementing vitamin K2 and magnesium.
Vitamin D3: Low levels are associated with increased cancer risk and bone metastases. Supplementing D3 (2000–4000 IU daily) is shown to reduce advanced cancer incidence.
Vitamin K2: Essential for directing calcium to bones (not arteries!), reducing fracture risk dramatically in meta-analyses.
Magnesium: Required for activating D3, the “missing link” for optimal absorption and avoiding calcification.
Studies warn that supplementing calcium and D3 alone can cause arterial calcification and increase cardiovascular risk so always combine D3, K2, and a chelated magnesium, such as magnesium glycinate, for the greatest benefit.
Managing Complications - Lymphedema, Raynaud’s, Osteopaenia, and Osteoporosis
Comprehensive cancer care extends beyond tumour control:
Lymphedema: Regular exercise (especially water aerobics), compression techniques, and supplements with anti-inflammatory action show benefits.
Raynaud’s Disease: Circulation boosting herbs (like ginger), consistent exercise, stress management, and keeping warm all help manage symptoms.
Osteopaenia/Osteoporosis: Weight-bearing exercise, balanced nutrition, K2/D3/magnesium trio, and regular follow-up with a bone specialist are recommended.
Recommended Supplement Protocol
Discuss with your oncologist:
Annatto Tocotrienol: 300mg twice daily
Geranylgeraniol (GG): One daily
Vitamin D3: 2000–4000 IU daily (to maintain optimal serum 40–60 ng/mL)
Vitamin K2 (MK-7): 180–200 mcg daily
Chelated Magnesium: 400–600 mg daily
Staying Hopeful and Engaged
ILC may be stealthy, but the combination of traditional medicine and targeted nutraceuticals can slow disease and improve well-being. Many patients are living well—and living longer—thanks to advances in integrative care.
At Natural Health Connect, we urge everyone affected by ILC and bone metastases to seek out an oncology team that welcomes nutritional support as a valued companion to conventional treatment.
If you have invasive lobular breast cancer or know someone who does, share these insights and resources and follow Natural Health Connect for continued updates, patient stories, and provider lists that support integrative healing.
Dr. Barrie Tan, Ph.D., has spoken extensively on tocotrienols (vitamin E compounds from annatto) and their potential roles in breast cancer, including interviews, articles, and clinical trial commentary. Several YouTube videos and podcasts feature his discussions on cancer prevention and breast cancer specifically.
The Research Behind Tocotrienol - Dr. Barrie Tan Ph.d
Conversations on Healing - Dr. Barrie Tan
YouTube Videos Featuring Dr. Barrie Tan
"The HEALTH and CANCER FIGHTING Benefits of Vitamin E / Annatto": Dr Tan discusses annatto tocotrienols and their anti-cancer mechanisms, including the inhibition of cancer cell signaling, cholesterol synthesis, and tumor angiogenesis. Breast cancer is referenced in the context of clinical trials underway.
The HEALTH and CANCER FIGHTING Benefits of Vitamin E / Annatto
"The Potential Health and Cancer Fighting Benefits of Annatto E": This video includes broader cancer discussions where tocotrienol’s clinical and preclinical effects are mentioned.
The Potential Health and Cancer Fighting Benefits of Annatto E with Barrie Tan, Ph.D.
These videos are accessible on YouTube via the provided links and the titles listed above.
Articles and Interviews
Integrative Touch Interview: Dr. Tan details promising clinical trials investigating tocotrienol for breast and pancreatic cancers, and explains key mechanisms for cancer suppression, including signal disruption, inhibition of cholesterol synthesis, and cutting off tumor blood supply. Conversations on Healing - Dr. Barrie Tan
BarrieTan.com – Research Behind Tocotrienol: The site summarizes both clinical and preclinical findings, stating that tocotrienol has been shown to be beneficial in clinical trials for ovarian and pancreatic cancers, and in preclinical studies (animal and cell models) for breast cancer. Key mechanisms include NF-Kappa B inhibition and anti-angiogenesis.
https://barrietan.com/why-tocotrienol/research-behind-tocotrienol/
ScienceDirect (Tan, 1992): Dr. Tan's early preclinical animal research showed antitumor effects of tocotrienols in female mice, including against mammary (breast) tumors.
https://www.sciencedirect.com/science/article/abs/pii/S0271531705804610
Clinical Research and Published Evidence
Publications and reviews (including the Malaysian TRF trial) cite Dr. Tan’s research, noting that tocotrienols have shown promise as adjuvants for breast cancer therapy, reducing recurrence and possibly mortality when combined with standard treatments, though more large clinical trials are needed for confirmation.
Further Reading and Listening
For a comprehensive overview, see:
The Integrative Touch podcast with Dr. Barrie Tan (discusses breast cancer clinical trial details and mechanisms).
BarrieTan.com research page (summarizes relevant mechanisms and studies).
YouTube videos "The HEALTH and CANCER FIGHTING Benefits of Vitamin E / Annatto" and "The Potential Health and Cancer Fighting Benefits of Annatto E" for direct video content.
These resources provide detailed, research-backed insights into Dr. Barrie Tan’s work on tocotrienols and breast cancer, including both mechanistic explanations and clinical trial progress.
Other References
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2773074
https://melioguide.com/osteoporosis-nutrition/vitamin-k2-for-osteoporosis/
https://www.wbcil.com/blog/why-magnesium-chelate-is-a-game-changer-for-health-and-wellness/
https://www.medicalnewstoday.com/articles/natural-treatment-for-osteoporosis.
Disclaimer:
The information provided on this website is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment (Refer to our Terms and Conditions). Content published on Natural Health Connect should not be relied upon as a substitute for professional medical advice from a qualified healthcare provider. Always consult your doctor or treating specialist before making any changes to your healthcare, medications, or supplement regimen. The owners and authors are not responsible for any loss, injury, or damages arising from reliance on this content.